Diverse range of small peptides associated with high-density lipoprotein - PubMed (original) (raw)
Diverse range of small peptides associated with high-density lipoprotein
Glen L Hortin et al. Biochem Biophys Res Commun. 2006.
Abstract
High-density lipoproteins (HDL) were examined as potential carriers of small peptides in plasma. HDL purified by density gradient centrifugation was delipidated and fractionated by size-exclusion chromatography under denaturing conditions. By HPLC and mass spectrometry, more than 100 peptide components were found in the size range from 1000 to 5000 Da. By sequence analysis, peptides were identified as fragments of proteins such as apolipoproteins, fibrinogen, alpha1-proteinase inhibitor, and transthyretin. The results indicate that purified HDL bears a complex range of small peptides. It is unclear whether the peptides have any significant functional role as apolipopeptides, but they may represent a pathway for peptide delivery or scavenging and a significant reservoir of plasma peptides for diagnostic evaluation.
Figures
Fig. 1
Analysis by hplc of 3 pools of HDL-associated peptides. The three pools were from size-exclusion chromatography of HDL-associated peptides with approximate size ranges of 3–6 kDa, panel A; 2–4 kDa, panel B; 1–3 kDa, panel C.
Fig. 2
Analysis of hplc fractions by MALDI TOF mass spectrometry. Each fraction was collected for 1 min, and 1 μL out of a total of 400 μL for each fraction was analyzed as described in Methods.
Similar articles
- Mass spectrometry-based analytical tools for the molecular protein characterization of human plasma lipoproteins.
Heller M, Stalder D, Schlappritzi E, Hayn G, Matter U, Haeberli A. Heller M, et al. Proteomics. 2005 Jul;5(10):2619-30. doi: 10.1002/pmic.200401233. Proteomics. 2005. PMID: 15892164 - Proteomic analysis of high-density lipoprotein.
Rezaee F, Casetta B, Levels JH, Speijer D, Meijers JC. Rezaee F, et al. Proteomics. 2006 Jan;6(2):721-30. doi: 10.1002/pmic.200500191. Proteomics. 2006. PMID: 16419016 - Application of 2-D free-flow electrophoresis/RP-HPLC for proteomic analysis of human plasma depleted of multi high-abundance proteins.
Moritz RL, Clippingdale AB, Kapp EA, Eddes JS, Ji H, Gilbert S, Connolly LM, Simpson RJ. Moritz RL, et al. Proteomics. 2005 Aug;5(13):3402-13. doi: 10.1002/pmic.200500096. Proteomics. 2005. PMID: 16052629 - Mass Spectrometry-Based Proteomic Study Makes High-Density Lipoprotein a Biomarker for Atherosclerotic Vascular Disease.
Chang CT, Yang CY, Tsai FJ, Lin SY, Chen CJ. Chang CT, et al. Biomed Res Int. 2015;2015:164846. doi: 10.1155/2015/164846. Epub 2015 May 18. Biomed Res Int. 2015. PMID: 26090384 Free PMC article. Review. - Flow field-flow fractionation: a pre-analytical method for proteomics.
Reschiglian P, Moon MH. Reschiglian P, et al. J Proteomics. 2008 Aug 21;71(3):265-76. doi: 10.1016/j.jprot.2008.06.002. Epub 2008 Jun 10. J Proteomics. 2008. PMID: 18602503 Review.
Cited by
- New roles of HDL in inflammation and hematopoiesis.
Zhu X, Parks JS. Zhu X, et al. Annu Rev Nutr. 2012 Aug 21;32:161-82. doi: 10.1146/annurev-nutr-071811-150709. Epub 2012 Apr 23. Annu Rev Nutr. 2012. PMID: 22540255 Free PMC article. Review. - Lipoproteomics: using mass spectrometry-based proteomics to explore the assembly, structure, and function of lipoproteins.
Hoofnagle AN, Heinecke JW. Hoofnagle AN, et al. J Lipid Res. 2009 Oct;50(10):1967-75. doi: 10.1194/jlr.R900015-JLR200. J Lipid Res. 2009. PMID: 19738003 Free PMC article. Review. - High-Density Lipoprotein Proteomics: Identifying New Drug Targets and Biomarkers by Understanding Functionality.
Gordon S, Durairaj A, Lu JL, Davidson WS. Gordon S, et al. Curr Cardiovasc Risk Rep. 2010;4(1):1-8. doi: 10.1007/s12170-009-0069-9. Curr Cardiovasc Risk Rep. 2010. PMID: 20625533 Free PMC article. - Proteomics investigations of HDL: challenges and promise.
Vaisar T. Vaisar T. Curr Vasc Pharmacol. 2012 Jul;10(4):410-21. doi: 10.2174/157016112800812755. Curr Vasc Pharmacol. 2012. PMID: 22339300 Free PMC article. Review. - HDL: bridging past and present with a look at the future.
Scanu AM, Edelstein C. Scanu AM, et al. FASEB J. 2008 Dec;22(12):4044-54. doi: 10.1096/fj.08-117150. Epub 2008 Aug 20. FASEB J. 2008. PMID: 18716026 Free PMC article. Review.
References
- Gotto A, Jr, Pownall HJ, Havel RJ. Introduction to the plasma lipoprteins. Meth Enzymol. 1986;128:3–41. - PubMed
- Brewer HB, Jr, Remaley AT, Neufeld EB, Basso F, Joyce C. Regulation of plasma high-density lipoprotein levels by the ABCA1 transporter and the emerging role of high-density lipoprotein in the treatment of cardiovascular disease. Arterioscler Thromb Vasc Biol. 2004;24:1755–1760. - PubMed
- Ribaya-Mercado JD, Ordovas JM, Russell RM. Effect of beta-carotene supplementation on the concentrations and distribution of carotenoids, vitamin E, vitamin A, and cholesterol in plasma lipoprotein and non-lipoprotein fractions in healthy older women. J Am Coll Nutr. 1995;14:614–620. - PubMed
- Goulinet S, Chapman MJ. Plasma LDL and HDL subspecies are heterogenous in particle content of tocopherols and oxygenated and hydrocarbon carotenoids. Relevance to oxidative resistance and atherogenesis. Arterioscler Thromb Vasc Dis. 1997;17:786–796. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials